Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients

Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival

(2013) D. Garbay et al.   ANNALS OF ONCOLOGY

Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer

(2012) Yasuhiro Terazaki et al.   CANCER SCIENCE

Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination

(2011) Masanori Noguchi et al.   CANCER BIOLOGY & THERAPY

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling

(2011) Simon A. Jones et al.   JOURNAL OF CLINICAL INVESTIGATION

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

(2011) Alberto S. Pappo et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

(2011) Sant P. Chawla et al.   JOURNAL OF CLINICAL ONCOLOGY

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer

(2010) Masanori Noguchi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines

(2010) Tetsuro Sasada et al.   EUROPEAN JOURNAL OF CANCER

Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor

(2010) Ilaria Marigo et al.   IMMUNITY

Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme

(2010) Mizuhiko Terasaki et al.   JOURNAL OF CLINICAL ONCOLOGY

Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells

(2010) M. G. Lechner et al.   JOURNAL OF IMMUNOLOGY

Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients

(2009) Takashi Hattori et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors

(2008) Keith M Skubitz et al.   Journal of Translational Medicine

The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer

(2008) Willscott E. Naugler et al.   TRENDS IN MOLECULAR MEDICINE